No Data
Hims & Hers, LifeMD Shares Soar 20+% Amid Novo Nordisk Deal for Weight-Loss Drugs
H.C. Wainwright Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $14
LifeMD, Inc. (NASDAQ:LFMD) Soars 58% But It's A Story Of Risk Vs Reward
Express News | HC Wainwright & Co. Reiterates Buy on LifeMD, Maintains $14 Price Target
LifeMD Analyst Ratings
Why New Wegovy Deals Won't Restore Novo's Obesity Lead -- Heard on the Street -- WSJ
loading...